BR9808428A - Composição farmacêutica, processo para tratar distúrbios alérgicos em um mamìfero e forma de dosagem unitária sólida - Google Patents
Composição farmacêutica, processo para tratar distúrbios alérgicos em um mamìfero e forma de dosagem unitária sólidaInfo
- Publication number
- BR9808428A BR9808428A BR9808428-3A BR9808428A BR9808428A BR 9808428 A BR9808428 A BR 9808428A BR 9808428 A BR9808428 A BR 9808428A BR 9808428 A BR9808428 A BR 9808428A
- Authority
- BR
- Brazil
- Prior art keywords
- dosage form
- pharmaceutical composition
- unit dosage
- solid unit
- allergic disorders
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 230000000172 allergic effect Effects 0.000 title abstract 2
- 208000010668 atopic eczema Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000007892 solid unit dosage form Substances 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 title 1
- SFOVDSLXFUGAIV-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]-n-piperidin-4-ylbenzimidazol-2-amine Chemical compound C1=CC(F)=CC=C1CN1C2=CC=CC=C2N=C1NC1CCNCC1 SFOVDSLXFUGAIV-UHFFFAOYSA-N 0.000 abstract 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82447797A | 1997-03-26 | 1997-03-26 | |
| US85178697A | 1997-05-06 | 1997-05-06 | |
| PCT/US1998/005701 WO1998042379A2 (en) | 1997-03-26 | 1998-03-25 | Chemically and thermally stable norastemizole formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9808428A true BR9808428A (pt) | 2000-05-23 |
Family
ID=27124816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9808428-3A BR9808428A (pt) | 1997-03-26 | 1998-03-25 | Composição farmacêutica, processo para tratar distúrbios alérgicos em um mamìfero e forma de dosagem unitária sólida |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1035869A1 (xx) |
| JP (1) | JP2002512614A (xx) |
| KR (1) | KR20010005746A (xx) |
| CN (1) | CN1257431A (xx) |
| AR (1) | AR012187A1 (xx) |
| BR (1) | BR9808428A (xx) |
| CA (1) | CA2284705A1 (xx) |
| HU (1) | HUP0001823A3 (xx) |
| NO (1) | NO994655L (xx) |
| NZ (3) | NZ517472A (xx) |
| RU (1) | RU2214245C2 (xx) |
| WO (1) | WO1998042379A2 (xx) |
| ZA (1) | ZA982562B (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ20002567A3 (cs) | 2000-07-11 | 2001-12-12 | Léčiva, A.S. | Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby |
| EP2201982A1 (en) * | 2008-12-24 | 2010-06-30 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Histamine H4 receptor antagonists for the treatment of vestibular disorders |
| EP2496217B1 (en) * | 2009-08-24 | 2019-03-27 | Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi | Direct compression tablets of otilonium |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE79620T1 (de) * | 1986-02-03 | 1992-09-15 | Janssen Pharmaceutica Nv | N-heterozyklische-4-piperidinamine enthaltende anti-histaminische zusammensetzungen. |
| DE4037426A1 (de) * | 1990-11-24 | 1992-05-27 | Kali Chemie Pharma Gmbh | Piperidinoalkylbenzoxazin- und -thiazin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE69327328T2 (de) * | 1992-09-03 | 2000-06-21 | Sepracor Inc., Marlborough | Verwendund von norastemizol zur behandlung der allergischen rhinitis |
| JPH11513991A (ja) * | 1995-11-17 | 1999-11-30 | ヘキスト・マリオン・ルセル・インコーポレイテツド | アレルギー性疾患の治療に有用な置換４−（１ｈ−ベンズイミダゾル−２−イル−アミノ）ピペリジン |
| IL128573A0 (en) * | 1996-08-16 | 2000-01-31 | Schering Corp | Treatment of upper airway allergic responses with a combination of histamine receptor antagonists |
-
1998
- 1998-03-25 BR BR9808428-3A patent/BR9808428A/pt not_active IP Right Cessation
- 1998-03-25 RU RU99122607/14A patent/RU2214245C2/ru not_active IP Right Cessation
- 1998-03-25 EP EP98914283A patent/EP1035869A1/en not_active Withdrawn
- 1998-03-25 NZ NZ517472A patent/NZ517472A/en unknown
- 1998-03-25 HU HU0001823A patent/HUP0001823A3/hu unknown
- 1998-03-25 NZ NZ527201A patent/NZ527201A/xx unknown
- 1998-03-25 CN CN98805457A patent/CN1257431A/zh active Pending
- 1998-03-25 NZ NZ52720098A patent/NZ527200A/xx unknown
- 1998-03-25 KR KR1019997008817A patent/KR20010005746A/ko not_active Application Discontinuation
- 1998-03-25 CA CA002284705A patent/CA2284705A1/en not_active Abandoned
- 1998-03-25 WO PCT/US1998/005701 patent/WO1998042379A2/en not_active Application Discontinuation
- 1998-03-25 JP JP54589398A patent/JP2002512614A/ja active Pending
- 1998-03-26 ZA ZA982562A patent/ZA982562B/xx unknown
- 1998-03-26 AR ARP980101398A patent/AR012187A1/es unknown
-
1999
- 1999-09-24 NO NO994655A patent/NO994655L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2284705A1 (en) | 1998-10-01 |
| KR20010005746A (ko) | 2001-01-15 |
| RU2214245C2 (ru) | 2003-10-20 |
| ZA982562B (en) | 1998-10-01 |
| WO1998042379A3 (en) | 2001-03-01 |
| HUP0001823A3 (en) | 2002-04-29 |
| NZ527200A (en) | 2004-12-24 |
| AU6868098A (en) | 1998-10-20 |
| WO1998042379A2 (en) | 1998-10-01 |
| AR012187A1 (es) | 2000-09-27 |
| NO994655D0 (no) | 1999-09-24 |
| CN1257431A (zh) | 2000-06-21 |
| AU735257B2 (en) | 2001-07-05 |
| HUP0001823A2 (hu) | 2001-04-28 |
| EP1035869A1 (en) | 2000-09-20 |
| NO994655L (no) | 1999-11-15 |
| NZ517472A (en) | 2003-08-29 |
| NZ527201A (en) | 2004-12-24 |
| JP2002512614A (ja) | 2002-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9806157A (pt) | Composições farmacêuticas de descarboetoxiloratadina anidras, não higroscópicas e sem lactose | |
| BR0012590A (pt) | Composto, processo para a preparação do mesmo, formulação farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de dor ou desconforto, e para tratamento ou profilaxia de dor neuropática ou central | |
| BRPI0110914B8 (pt) | 'composição farmacêutica líquida, processo para preparação da mesma e uso de uma composicão farmacêutica' | |
| BR9810097A (pt) | Derivados de macrolìdeos c-4-substituìdos | |
| DK0668863T3 (da) | Quinuclidinderivat som substans P-antagonist | |
| BR0315988A (pt) | Derivados de diidropirimido[4,5-d]pirimidinona substituìda por amino, sua produção e uso como agentes farmacêuticos | |
| NO20040547L (no) | Amino-ftalazinonderivater aktive som kinaseinhibitorer, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende disse. | |
| WO2001098290A3 (en) | Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | |
| BR9814375A (pt) | Inibição de raf cinase usando difenil uréias substituìdas simétricas e assimétricas | |
| BR0009043A (pt) | Composto, composição farmacêutica, e, método de tratar uma doença em um animal em que a atividade da cisteìna protease contribui para a patologia e/ou sintomatologia da doença | |
| BR0316234A (pt) | Hidroxiindóis, seu uso como inibidores de fosfodiesterase 4 e processos para a preparação dos mesmos | |
| BR0308739A (pt) | Tratamentos em combinação para doenças mediadas por quimiocina | |
| BRPI0408523A (pt) | métodos para melhorar um sintoma de esclerose múltipla em um indivìduo, para melhorar esclerose múltipla em um indivìduo mamìfero, para modular uma deficiência de il-10, ou um distúrbio associado com uma deficiência de il-10 em um indivìduo mamìfero, para tratar ou prevenir um distúrbio imunológico em um indivìduo mamìfero e para avaliar o tratamento de esclerose múltipla em um indivìduo mamìfero, composição farmacêutica, e, artigo de manufatura | |
| BR9807673A (pt) | Processos para tratar asma alérgica e dermatite em um humano e composição farmacêutica. | |
| BR9714677A (pt) | "enantiÈmeros 3-piridila e seu uso como analgésicos" | |
| BR9507073A (pt) | Composto processos para preparar o mesmo e para tratar uma doença no sistema nervoso central composiçao farmacêutica e uso do composto | |
| BRPI0415050A (pt) | composto, formulação farmacêutica, método para tratar ou reduzir risco de uma doença ou condição humanas, uso de um composto ou de um sal deste farmaceuticamente aceitável, e, processo para a preparação de um composto ou de um sal deste farmaceuticamente aceitável | |
| DE69830492D1 (de) | Antikörper als ARZNEIMITTEL GEGEN LYMPHOCYTISCHE TUMORE (AUSSCHLIESSLICH MYELOME) | |
| BRPI0408486A (pt) | derivados de biciclopirazol ativos como inibidores da cinase, processo para a sua preparação e composições farmacêuticas compreendendo-os | |
| BR9909118A (pt) | Composição farmacêutica, comprimido, forma de dosagem unitária farmacêutica sólida estável, e, processo para tratar depressão em um mamìfero | |
| PT984019E (pt) | Carbamatos antibacterianos em c11 de macrolidos | |
| BR9814498A (pt) | Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica | |
| BRPI0409818A (pt) | compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos | |
| BR9808428A (pt) | Composição farmacêutica, processo para tratar distúrbios alérgicos em um mamìfero e forma de dosagem unitária sólida | |
| BR9611642A (pt) | Compostos composição farmacéutica e processo para a preparação de compostos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A E 9A ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1908 DE 31/07/2007. |